TL;DR: Private label supplement brands are responsible for every claim on their labels, listings, and ads, even when a partner fills and ships the bottles. Amazon now requires third-party verification for supplements sold in its US store, and the FTC expects health claims to be backed by competent and reliable scientific evidence. On Demand Fulfillment (ODF, ondemandfulfillment.com) is a private label supplement fulfillment and dropshipping company that helps founders launch with no minimums, using supplements sourced from NSF-certified, cGMP-compliant facilities that are 3rd Party Tested.

On a recent episode of the On Demand Fulfillment Podcast, our CEO Daniel Lindsey sat down with Brian Yam, CEO and Chief Consultant of Blue Ocean Regulatory. Brian has worked in supplement regulatory affairs and quality assurance since 2004, first on the manufacturing side and now with brands. One idea came up again and again: the brand is the party that regulators, marketplaces, and retailers hold accountable. This article covers what that means in practice for a new or growing private label brand.

Who is responsible for supplement label claims, the brand or the supplier?

The brand is responsible. Brian explained that many new founders assume their supplier will take care of compliance for them, and that assumption only covers part of the picture. A good supplier confirms what goes into the bottle and that the Supplement Facts panel is accurate. The brand owns how the supplement is described to customers: the label claims, the website copy, the ads, and the social posts.

The pressure grows as a brand expands into new channels. Brian noted that Amazon and retail chains place their compliance requirements on the brand, not on the facility that filled the bottle. A brand that sells through several channels needs to know what each one expects.

He also cautioned that certifications are a starting point rather than the finish line. He compared them to a driver’s license. Two people can hold the same license and drive very differently. A certification confirms that a facility can meet a standard, and the brand still benefits from paying attention to how that standard is carried out.

What did Amazon change for supplement sellers?

Amazon now requires third-party verification for supplements sold in its US store. Under the policy that took effect on April 2, 2024, supplements must be verified through an approved third-party testing, inspection, and certification (TIC) organization (NSF). Amazon accepts certificates of analysis directly from its partner TIC organizations, and listings that are not verified by the due date are subject to removal (Nutraceuticals World).

Brian said Amazon is also looking harder at label claims that can mislead shoppers. His example was a label that advertises 10,000 mg of a botanical when the capsule holds a much smaller amount of a concentrated extract. The larger number comes from an extract ratio. A shopper reads it as 10,000 mg in the capsule, and Amazon now treats that gap as a problem.

The practical takeaway is simple. Keep your listing consistent with your Supplement Facts panel, and either explain equivalency numbers clearly or leave them out.

Why does the FTC care about words like “natural” and “clean”?

The FTC cares because it judges a claim by how consumers are likely to interpret it. In December 2022, the FTC released its Health Products Compliance Guidance, which replaced its 1998 advertising guide for dietary supplements. The guidance reaffirms that health benefit claims require competent and reliable scientific evidence (Covington). Since the 1998 guide was published, the FTC has filed more than 200 cases challenging false or misleading advertising for supplements and other health-related goods (Natural Products Insider).

Brian used “100% natural” as his example. To a founder, the phrase sounds harmless. One consumer may read it as “made from botanicals.” Another may read it as a promise of safety. A third may read it as “no processing at all.” Every capsule involves some processing, and that gap between the words and the reality is where lawsuits start.

His advice was to substantiate any claim with evidence you could defend, and to understand the risk before you print it. That applies to labels, websites, social posts, and ads alike, because the FTC and FDA share oversight of how supplements are marketed.

What compliance steps should a new private label brand take first?

A new brand should start with a scaled-down version of the program that larger brands run. Brian described early-stage compliance as an investment of a few thousand dollars, focused on testing, labels, and website copy. Larger brands that sell through retail and marketplaces need deeper programs with written procedures, a recall plan, and a quality assurance function. He noted that bringing in outside QA support often costs less than building that team in-house.

For a brand that is just getting started, these five steps cover the basics:

  1. Collect testing documentation for every supplement you sell, and keep it organized by lot.
  2. Check every label claim against the Supplement Facts panel, especially amounts and extract ratios.
  3. Review your website, ads, and social posts for claims that go beyond structure and function. Disease claims are off-limits for supplements.
  4. Learn each channel’s rules before you list. Amazon’s TIC verification is the best-known example.
  5. Plan for growth. Once you reach retail or meaningful volume, add a recall plan and QA procedures, or work with an outside regulatory partner.

The market is large enough that regulators and marketplaces will keep paying attention. According to the Council for Responsible Nutrition’s 2023 consumer survey, 74% of US adults take dietary supplements, and 55% are regular users (Nutritional Outlook).

How does choosing the right supplements make compliance easier?

Starting with well-documented supplements gives a brand a head start. When a brand launches with supplements sourced from NSF-certified, cGMP-compliant facilities that are 3rd Party Tested, it starts with testing documentation in hand rather than chasing it later. As Brian pointed out, certifications are only part of compliance, so the brand still needs to review its claims, listings, and marketing.

That is the foundation On Demand Fulfillment (ODF) provides. ODF offers 80+ private label supplements in its catalog, with no minimums, so founders can launch one supplement or a full line without buying inventory. Orders are fulfilled in the USA within 24 hours, and more than 500 brands use ODF today. ODF’s team reviews label content during private label setup, while final responsibility for marketing claims stays with the brand. ODF does not provide legal advice, so brands with complex claims should work with a regulatory consultant like Blue Ocean Regulatory.

Frequently asked questions

Do private label supplements need FDA approval?
No. Dietary supplements do not require FDA approval before they are sold. Supplements must be made under cGMP requirements and labeled accurately, and the brand is responsible for the claims it makes.

Is my supplier responsible for my label claims?
No. Your supplier is responsible for making the supplement to specification under cGMP. Your brand, as the company named on the label, is responsible for everything on that label, including the Supplement Facts panel, and for how the supplement is described on listings, websites, and ads.

Does Amazon require third-party testing for supplements?
Yes. Since April 2, 2024, supplements sold in Amazon’s US store must be verified through an approved third-party testing, inspection, and certification organization. Listings that are not verified can be removed.

Can I call my supplement “all natural”?
You can, but the FTC judges the claim by how consumers interpret it. Because shoppers read “natural” in different ways, you need evidence that supports the specific meaning your customers are likely to take from it.

What is the difference between FDA and FTC rules for supplements?
The FDA focuses on how supplements are made and labeled. The FTC focuses on advertising and marketing claims. The two agencies share oversight, so a brand needs to meet both.

When should a supplement brand hire a regulatory consultant?
Most brands benefit from a consultant before launch for a label and website review, and again when they expand into Amazon, retail, or a larger catalog.

Ready to launch on a solid foundation?

Start your private label supplement brand with supplements that are 3rd Party Tested, fulfilled in the USA, and available with no minimums. Get started with ODF today, or see how it works.

Episode chapters

  • 0:00 Intro
  • 0:07 Meet Brian Yam of Blue Ocean Regulatory
  • 2:29 Compliance for new brands vs. established brands
  • 4:49 Why certifications are only part of compliance
  • 6:26 The FTC, “100% natural,” and “clean” claims
  • 9:43 What Amazon is changing for supplement sellers
  • 11:54 Should supplement ingredients need FDA approval?
  • 14:57 Using AI in regulatory work
  • 19:45 How to connect with Brian
  • 20:24 Outro
Read the full transcript

This transcript was generated from the episode audio and lightly edited for readability. It is for general information only and is not legal or regulatory advice.

Daniel Lindsey (0:06): Welcome back to the podcast, guys. Today we have Brian Yam with Blue Ocean Regulatory. Brian, why don’t you give us a little bit of background about what you do there and the areas you specialize in.

Brian Yam (0:16): Sure. Well, good to connect with you. My name is Brian Yam. I specialize in regulatory affairs, quality assurance, and compliance in the dietary supplement space. I started back in 2004, so I’ve been in this market for quite a while, specializing in compliance and helping brands understand and navigate FDA and FTC requirements. I’ve been on the manufacturing side, and more recently I’ve specialized on the brand side. It’s a different level of compliance. We work with clients that range from brand-spanking-new startups to established brands, say $50 million a year or under. They’re either brand new to this, or maybe they got their hands slapped and are now realizing this compliance thing actually is a thing, and they have to figure out what they want to do at the brand level. That’s what we’re doing now. We work in both the US market and the Canadian market, but for the purpose of today, I believe we’re talking about the US market.

Daniel Lindsey (1:06): I’d be open to hearing about both, honestly, because sometimes people sell a lot in the US and try to move their brands into Canada as well, and there can be a lot of unknowns. So having an agency like yours that knows both is, I’m sure, super valuable. I also think it’s valuable that you have that background on the manufacturing side, because we look at that a lot too when we’re vetting our manufacturers and suppliers and making sure they’re compliant. It can be a pretty strict world to live in with the FDA. So you’ve been with Blue Ocean Regulatory for about five years now. Is that right?

Brian Yam (1:41): Yeah, correct. Consulting is very different from corporate life. During COVID we moved from a metropolitan area of Canada to a more rural part of the country and haven’t looked back. At the same time, the job market is very different here, so that’s when I started the company.

Daniel Lindsey (2:00): Awesome. It’s a very niche industry you’re in. I’ve never heard of an agency that specializes in this, especially with dietary supplements. We work with a ton of brands in that space. You mentioned brands under $50 million are often your ideal client, but if a brand is starting completely from scratch, what does working with you typically look like? Is it a pretty high budget, or does it depend on the scenario?

Brian Yam (2:29): There are two big buckets. There’s the brand-new entrepreneur who’s never done this before, maybe working with you, trying to get those first few products off the ground. Obviously, they don’t usually have a huge budget at that point. They’d work with us in those early phases: making sure the testing is done properly, the label is done properly, and the website is compliant. Essentially, we’re scaling compliance down to that level. I wouldn’t say it’s a huge investment, but depending on their budget, or just being new to this space, they may not know compliance even exists, or they work under the assumption that their supplier or manufacturer will take care of compliance for them. That’s not the full picture. You’re looking at a few thousand dollars to start if you really want to put some compliance measures in place at that level.

Then there’s the flip side. Maybe they’re doing a million dollars a year, $10 million a year or more, and they have a much broader portfolio. They’ve been in the market. Maybe they’re looking at distribution in some stores, and they’re realizing this business is taking on a life of its own. It’s becoming a real business, and they need to protect it. They’re realizing there are all these other elements downstream. Your distribution channels, like Amazon and retail stores such as Whole Foods, have compliance requirements they require of the brand, not necessarily of the manufacturer. The brand is the one they’re holding accountable, and a lot of brands are realizing this. That calls for a much more in-depth program: specific procedures, a recall plan, testing procedures, and most likely some sort of QA function at the headquarters level. That can be a lot more costly, and that’s really our bread and butter. We work with a lot of brands as their remote QA department. We initiate these procedures and then run them for them, and that’s where we become more integrated. It’s still cheaper than hiring your own QA.

Daniel Lindsey (4:22): I was about to say the same thing. It’s probably a fraction of what it would cost to build out the team internally, because I know a little bit about how much that costs.

Brian Yam (4:30): Bingo, that’s exactly it. Plus there’s the experience they’re getting. We work at an executive level, but we play across all the different functions, from executive advisor down to someone doing releases, checking testing parameters, and auditing your manufacturers.

Daniel Lindsey (4:46): Imagine the brand is working with a supplier or manufacturer that has NSF, FDA registration, cGMP, all the things they should have, and testing is provided easily. That saves a lot of headache, time, and probably cost for you and your team if they’ve already vetted a good supplier up front, right?

Brian Yam (5:03): Yes and no. It’s a good start for sure. As you get more involved in this space, and I’m sure you know this, Daniel, you realize these certifications only cover a fraction of compliance. A lot of the time it’s no different than getting a driver’s license. You and I have our driver’s licenses, and so does a 16- or 18-year-old, but the quality of how we drive is going to be very different. What we’re aware of, the checks we do, the shoulder checks, all the things we know through experience are built in over the years. Someone with a driver’s license technically can drive. Same with a contract manufacturer: technically they can make a product to NSF standards, but a lot of things get missed through execution and lack of experience. A lot of brands realize this and bring us in. We catch things an FDA auditor or an NSF auditor might not catch, and we tailor it to the brand level. There are certain things the brand might want that NSF and FDA don’t care about, but the brand really does, and we need to hold the manufacturer to those standards as well. So you’re right, those checks are very helpful, but we add that extra layer, and that’s usually what brands are looking for at that point.

Daniel Lindsey (6:26): That makes sense. I think I read that you also handle the FTC side of compliance, right? That’s a huge one we hardly touch on at all. We supply the products and label things, and we’re really focused on label compliance: making sure labels meet what they should, follow the rules, the Supplement Facts panels are accurate, and there are no outrageous claims on the bottles or labels. Outside of that, a lot of the time we don’t know what’s going on with these products. If you’re helping brands on the FTC side, I’d love to hear what that looks like, because that’s probably a pretty wide area to cover.

Brian Yam (7:00): You make a really good point, and typically I don’t expect manufacturers to look beyond what you just said. They know what goes into the formula, the ingredients, the other ingredients, and the testing. With the FTC, it really comes down to making sure the product is marketed in a way that isn’t misleading to the consumer. The FTC is trying to protect consumers and make sure they’re well aware of what the product is supposed to deliver before they make that buying decision.

What’s interesting, especially in this space, is that a lot of brands like to push the boundaries. An example would be as simple as a “clean” claim: “my product is 100% natural,” or “it’s clean.” To the average person, or even the entrepreneur, that’s a fairly innocent term. We’re using herbal botanicals. These are natural ingredients, not pharmaceutical drugs. But the FTC is thinking, wait a minute, what does “100% natural” really mean? To one consumer it may mean a botanical ingredient. Another may believe it promises another level of safety. To another person it might mean there’s no processing whatsoever. You get these different interpretations from consumers, and as a result you see lawsuits. A lawyer will say, “You said 100% natural. That means there’s no man-made process in the formula or the ingredients.” But you and I both know that to get these into capsules, there has to be some level of processing. That’s the FTC for you. It’s about perception: what does the consumer perceive? And there are businesses and lawyers out there that may over-interpret things and go after a brand. So even innocent claims like “clean” or “natural” carry some risk. It’s important that we properly substantiate them and make sure we have the right evidence to back them up, so we can defend ourselves if there’s ever an issue, and at minimum let the brand know the risks if they want to move ahead. It’s a completely different world. It’s connected with the FDA, but it’s a separate thing. It’s all about the marketing and the perception.

Daniel Lindsey (9:10): With some of these bigger brands that are building new sales funnels constantly, are you helping audit those, reviewing the content?

Brian Yam (9:18): If a client asks us to, yes. It depends on what kind of service they’re looking for and how deep they want us to go. Most of the time it’s labels and website content. Others want us to review their social media content or an advertisement. It really comes down to the client and what they want to prioritize.

Daniel Lindsey (9:43): That makes sense. I’m sure you’re deep in the news with the FDA, which is always changing and evolving. Is there anything this year that stands out as a big change coming up or a trend in that world?

Brian Yam (9:58): There are constant changes. Even when the regulations don’t change, the interpretation and the enforcement level change. Two big buckets come to mind, especially for your clientele. First, Amazon. Amazon has made some changes this year, and the big one is exactly the topic we just talked about: what’s misleading. They’re really cracking down on label claim issues. They want to make sure the product isn’t misleading. We’ve seen products on Amazon that say 10,000 milligrams of a botanical. The average person may think there are actually 10,000 milligrams of that in the capsule, but that’s not the case. It’s an extract at a certain extract ratio, there’s math involved, and that’s how they get to that number. Amazon is cracking down on that. So that whole idea of marketing and perception is a big change I think is coming down the pipeline for a lot of people on Amazon.

The other big change, or at least discussion in the industry right now, is how the MAHA movement is impacting supplements. If we look at RFK Jr. and what he’s doing with food dyes and GRAS status, they’re looking at mandatory FDA approval for GRAS and for other dietary ingredients. Right now, for many supplement ingredients on the market, lawfulness is determined by the industry, by the sellers of those ingredients. That’s acceptable under FDA rules today. But they’re evaluating whether that’s right, whether there’s a conflict of interest, and whether it should go through FDA approval. Then there’s the discussion about resources and how fast that could happen. There’s a camp in the industry that says this is good for the industry, and a camp that says it’s just more bureaucracy that will slow down innovation and hurt the industry. They both have their points, and I can see both sides. But those are the two big trends right now.

Daniel Lindsey (11:54): I don’t think I’d heard about that specifically in the dietary supplement world. I’d heard about the FDA trying to streamline approvals on the pharmaceutical side, but not that strict a level of enforcement being considered for dietary supplements. In some ways it’s an interesting industry that falls outside the usual categories. It’s not a food and it’s not a drug, so it borrows some rules from both. It would make sense for them to refine it with more specific requirements, but I’m sure it would make all of our jobs a lot harder if they do.

Brian Yam (12:31): I totally agree, and that’s the whole point of this discussion: talking to industry and figuring it out. It’s a tough one. Supplements don’t need any sort of FDA approval because they’re a subset of foods. You don’t need to get your bread or your muffins approved by the FDA. That’s how they see it. Separately, there’s talk about whether supplements should be approved by the FDA and go through some sort of listing process, but that’s more drug-like. I’m with you. It would be great to get some clarification and see where they’re really trying to go with this.

Daniel Lindsey (13:06): It’ll be interesting. One thing I was curious about: have you worked with any clients, or done initial consultations with clients, trying to get into the peptide space, even ingestible peptides?

Brian Yam (13:14): The one peptide I think everyone is thinking about is BPC-157. It’s a good example, and right now it’s a gray area. There’s the question of whether it’s a permitted dietary ingredient, and for BPC-157 I have my questions. My suspicion is that it won’t fall under the definition of a dietary ingredient. I’m sure viewers are thinking, “I see it on sale every day on Amazon.” Like I said, it’s a gray area, so we’ll see what happens. It’s hard to determine. I know some people are trying to skirt the rules by marketing it as a test product or test sample: “not a dietary supplement,” “research use only,” “not for human consumption.” I don’t know if that’s really defensible or a good tactic, but I see where they’re going, and we’ll see where it goes.

Daniel Lindsey (14:08): That’s where I’m interested, because most of the “research use only” products I’ve seen are injectables, which is a whole different level. You’re not typically injecting other dietary supplements. But if it moves to an ingestible, and the FDA doesn’t clear specific ingredients for other dietary supplements, what’s the difference between putting BPC-157 in a capsule and any other ingredient? I think that’s what created the gray area, because it hasn’t been defined as not being one yet. It’s a weird area.

Brian Yam (14:37): I’m with you. I remember there was a Men’s Health article on BPC-157 recently. I don’t know if you came across that.

Daniel Lindsey: I don’t think I’ve seen that one, but I’ve seen a lot of other coverage.

Brian Yam (14:46): It came out a couple of months ago, I believe, and it was a big write-up on BPC-157. There’s a lot of attention on this ingredient and a lot of demand for it, so I get it.

Daniel Lindsey (14:57): It’ll be interesting to see what happens over the coming years. One thing I like to ask guests, since it’s always evolving, is how you personally use AI in your industry. How much do you rely on it for initial vetting or quick reviews before you dive in? I’d love to hear from someone in a very strict regulatory world where the smallest details matter, whether you’ve found you can trust it for certain day-to-day tasks or you’re not quite there yet.

Brian Yam (15:31): That’s a really good question. First, I think the industry as a whole is typically slower to adopt AI. That said, I use it on a daily basis, and I was really hoping it would help streamline things. What I found is that you’re spending the time not doing the work but checking that the AI did it properly. It will produce all these results and tables for you, but is it true? Is it right? You have to go to the source. We’re coming across a lot of formulas from clients that are AI-driven, and they show all the references, but when we go into the references we find a couple of things. Either the references are completely fake, or they don’t meet FDA or FTC muster. The FDA and FTC have defined what they consider a competent level of evidence, and a lot of the time AI isn’t going through that exercise.

If I use AI today, it’s more to get a big-picture view, and then we have to go in and look at the source evidence, the actual clinical studies being cited. I’ve seen AI make up regulations. I know what the regulations are, and it will say something and I’ll think, no, you’re wrong, and I’ll spend 15 minutes arguing with this robot about why it’s wrong. That’s when I realized there are limitations. Right now I use it more for managing tasks, managing my day, and the easy stuff: what is this ingredient used for, getting a big-picture feel, or are there alternative ways to phrase certain claims. But the logic it uses to determine whether something is non-compliant isn’t perfect. It needs a nudge in the right strategic direction, and then it can produce some ideas. At the time of this filming, I think it’s quite limited. Is it saving time? I don’t know about you, but for me I can’t tell. I feel like more of my time goes to verifying and double-checking AI.

Daniel Lindsey (17:30): I can totally understand that feeling. For me it depends on the category of the task. Months ago I was using ChatGPT to research some FDA regulations and find the exact CFR code for something, and it kept telling me, “Right here, and here, and here.” I said, “Okay, give me the link to that specific CFR code,” and it couldn’t come up with it. I said, “No, this isn’t real,” and it said, “You’re right, thanks for calling me out on that.” Well, that was useless, because I wanted the reference on the FDA’s website so I could reply to an email and move the project forward. It’ll hallucinate and gaslight you into thinking it has the answer. I’ve found certain tools are worse at affirming what they think you want to hear, and I’ve had better luck with others sticking to the facts I provide. I use Claude a lot: I give it a whole folder full of resources, have it dig through all of that, and it brings out some great deep analysis and presentations that have been really accurate and solid. So it depends on the application and the tool. Sometimes I spend too much time trying to find the perfect tool versus just doing the task myself. It’s interesting, though. It’s entertaining.

Brian Yam (18:42): It’s funny you mention Claude. I think that’s the next one everyone is talking about, so we’ll definitely have to look into that. If you’re recommending it, I’ll check it out.

Daniel Lindsey (18:56): I really like it. I feel like it sticks to what you want it to do. It’s less conversational and less about affirming things. It’s just factual, and I’ve had better luck with the truthfulness of the results. There are other tools that are better for visual presentations, like Manus, which Meta bought, that make some really nice slideshows using Google’s Nano Banana. But I’ll use Claude to pull the facts together and make it clean, give it feedback over three or four iterations to get it dialed in, then take that into another tool to create a presentable slideshow for the board or the team. Having a tech stack of multiple tools, rather than doing it all in one, has been my best outcome.

Brian Yam (19:41): Very cool. Okay, I’ve got some checking out to do.

Daniel Lindsey (19:45): Sorry, now I’ve sent you down a rabbit hole. Well, Brian, I appreciate your time. I definitely learned more about the regulatory world. If we have listeners who want to make sure they’re up to date on all the current codes and requirements, what’s the best way to reach out to you and your team for an initial audit or consultation?

Brian Yam (20:03): Our website is blueoceanregulatory.com. You can email me, and we’ll set up a one-on-one to get a better understanding of your needs and see how, and if, we can help you.

Daniel Lindsey (20:15): Perfect. Brian, I really appreciate your time, and we’ll definitely keep you in mind for clients who need those services. Thank you for being willing to share your expertise with us today.

Brian Yam (20:23): Thank you. My pleasure.

Tim Ranagan, Director of Marketing, On Demand Fulfillment